| abstract |
The invention includes (a) compounds that inhibit HCV and salts thereof; (b) intermediates useful in preparing the compounds and salts; (c) compositions comprising the compounds and salts; (d) the intermediates. Methods for preparing bodies, compounds, salts and compositions; (e) methods of using the compounds, salts and compositions; and (f) kits containing the compounds, salts and compositions. The compounds are useful for the treatment of hepatitis C and have the general structure of formula (I). |